Tag
2 articles
Insilico Medicine has significantly shortened drug discovery timelines in China by combining AI with laboratory research, cutting development time to as little as nine months.
Takeda has entered a $600 million AI drug discovery collaboration with Insilico Medicine, leveraging AI to accelerate early-stage drug development across multiple therapeutic areas.
